Mitesco CEO granted 3M shares at $0.035

Q: What insider transactions did Mitesco (MITI) disclose for Brian Valania?

Mitesco disclosed that CEO and CFO Brian Valania received 3,421,078 total common shares through grants, including 3,000,000 shares at $0.035 on 2026-08-03 and earlier smaller grants, plus 7,200 shares of Series X Preferred Stock awarded in 2026.

Q: How many Mitesco (MITI) common shares were granted on 2026-08-03?

On 2026-08-03, Brian Valania received a grant of 3,000,000 shares of Mitesco common stock at a price of $0.035 per share, increasing his direct common stock ownership to 3,421,078 shares.

Q: What are the terms of Mitesco (MITI) Series X Preferred Stock granted to the CEO?

Brian Valania received 2,400 Series X Preferred shares on 2026-05-01 and 4,800 on 2026-07-10, totaling 7,200 shares. Each has a $400 stated value and, as disclosed, no conversion rights, is not exercisable, has no expiration date, and no underlying common shares.

Q: Do the Series X Preferred Stock grants at Mitesco (MITI) create potential dilution?

According to the disclosure, the Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of common stock underlying it. Based on this description, the reported Series X grants do not currently represent additional common share dilution.

Q: What earlier Mitesco (MITI) common stock grants to the CEO are reported?

Earlier reported grants to Brian Valania include 221,078 common shares at $0.08 per share on 2026-07-21 and 200,000 common shares at $0.25 per share on 2024-07-29, both classified as board-approved grant or award acquisitions.

Mitesco, Inc. (MITI) reported multiple board-approved equity grants to CEO and CFO Brian Valania.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Mitesco, Inc. (MITI) reported multiple board-approved equity grants to CEO and CFO Brian Valania. On 2026-08-03 he received a grant of 3,000,000 shares of Common Stock at $0.035 per share, which increased his direct common ownership to 3,421,078 shares. An earlier grant on 2026-07-21 added 221,078 common shares at $0.08 per share, and a 2024-07-29 grant added 200,000 common shares at $0.25 per share.

Valania also received Series X Preferred Stock awards: 2,400 shares on 2026-05-01 and 4,800 shares on 2026-07-10, bringing his direct holdings to 7,200 Series X preferred shares. Each Series X share has a $400 stated value and, as disclosed, has no conversion rights, is not exercisable, has no expiration date, and has no underlying common shares, so these preferred grants do not currently represent additional common equity.

Insider Trade Summary

Grant/Award: 3,428,278 shares

Grant/Award 5 txns

Insider Valania Brian

Role CEO and CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,000,000	$0.035	$105K
Grant/Award	Common Stock	221,078	$0.08	$18K
Grant/Award	Series X Pref. ^F1	4,800	$400.00	$1.92M
Grant/Award	Series X Pref. ^F1	2,400	$400.00	$960K
Grant/Award	Common Stock	200,000	$0.25	$50K

Holdings After Transaction: Series X Pref. — 7,200 contracts (Direct); Common Stock — 3,421,078 shares (Direct)

Footnotes (1)

F1. The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.

Key Figures

Common Stock grant on 2026-08-03: 3,000,000 shares at $0.035 per share Common Stock grant on 2026-07-21: 221,078 shares at $0.08 per share Common Stock grant on 2024-07-29: 200,000 shares at $0.25 per share +4 more

7 metrics

Common Stock grant on 2026-08-03 3,000,000 shares at $0.035 per share Board-approved grant of common stock to CEO/CFO Brian Valania

Common Stock grant on 2026-07-21 221,078 shares at $0.08 per share Board-approved grant of common stock to CEO/CFO Brian Valania

Common Stock grant on 2024-07-29 200,000 shares at $0.25 per share Board-approved grant of common stock to CEO/CFO Brian Valania

Direct common ownership after 2026-08-03 grant 3,421,078 shares Direct common stock holdings of Brian Valania following the 08/03/26 grant

Series X Preferred grant on 2026-05-01 2,400 shares at $400 stated value per share Board-approved Series X Preferred Stock grant to CEO/CFO Brian Valania

Series X Preferred grant on 2026-07-10 4,800 shares at $400 stated value per share Board-approved Series X Preferred Stock grant to CEO/CFO Brian Valania

Total Series X Preferred holdings after grants 7,200 shares Direct Series X Preferred Stock ownership of Brian Valania

Key Terms

Series X Preferred Stock, stated value, derivative, grant/award acquisition

4 terms

Series X Preferred Stock financial

"The Series X Preferred Stock has no conversion rights, is not exercisable"

Series X preferred stock is a specific class of company shares that gives holders priority over common shareholders for dividend payments and payout if the company is liquidated, often with a set dividend rate or special conversion or voting terms. Think of it as a VIP ticket in line: it usually offers more income stability and protection but less upside from stock price gains, so investors weigh steady returns and safety against limited growth potential.

stated value financial

"Series X has a $400 stated value; conversion terms and underlying"

Stated value is an accounting figure a company assigns to a share when the share has no par (legal) value; it becomes the portion of proceeds recorded as the company’s permanent capital for regulatory and bookkeeping purposes. It matters to investors because it affects the equity reported on the balance sheet and the legal limits on distributions or dividend payments, but it is not the market price — think of it as a record-keeping sticker price rather than what buyers actually pay.

derivative financial

"transaction_type": "derivative""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

FAQ

What insider transactions did Mitesco (MITI) disclose for Brian Valania?

Mitesco disclosed that CEO and CFO Brian Valania received 3,421,078 total common shares through grants, including 3,000,000 shares at $0.035 on 2026-08-03 and earlier smaller grants, plus 7,200 shares of Series X Preferred Stock awarded in 2026.

How many Mitesco (MITI) common shares were granted on 2026-08-03?

On 2026-08-03, Brian Valania received a grant of 3,000,000 shares of Mitesco common stock at a price of $0.035 per share, increasing his direct common stock ownership to 3,421,078 shares.

What are the terms of Mitesco (MITI) Series X Preferred Stock granted to the CEO?

Brian Valania received 2,400 Series X Preferred shares on 2026-05-01 and 4,800 on 2026-07-10, totaling 7,200 shares. Each has a $400 stated value and, as disclosed, no conversion rights, is not exercisable, has no expiration date, and no underlying common shares.

Do the Series X Preferred Stock grants at Mitesco (MITI) create potential dilution?

According to the disclosure, the Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of common stock underlying it. Based on this description, the reported Series X grants do not currently represent additional common share dilution.

What earlier Mitesco (MITI) common stock grants to the CEO are reported?

Earlier reported grants to Brian Valania include 221,078 common shares at $0.08 per share on 2026-07-21 and 200,000 common shares at $0.25 per share on 2024-07-29, both classified as board-approved grant or award acquisitions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/24/2026 - 05:33 PM Accepted by SEC EDGAR 08/24/2026 - 05:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Valania Brian

(Last)

(First)

(Middle)

505 BEACHLAND BLVD.

SUITE 1-377

(Street)

VERO BEACH

FLORIDA

32963

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Mitesco, Inc. [ MITI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2024

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/29/2024		A		200,000	A	$0.25	200,000	D
Common Stock	07/21/2026		A		221,078	A	$0.08	421,078	D
Common Stock	08/03/2026		A		3,000,000	A	$0.035	3,421,078	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series X Pref.	⁽¹⁾	05/01/2026		A		2,400		⁽¹⁾	⁽¹⁾	Common	0	$400	2,400	D
Series X Pref.	⁽¹⁾	07/10/2026		A		4,800		⁽¹⁾	⁽¹⁾	Common	0	$400	7,200	D

Explanation of Responses:

1. The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.

Remarks:

Board-approved grants. The 07/10/26 common grant increased direct ownership to 421,078 shares; the 08/03/26 common grant increased it to 3,421,078 shares. The 07/10/26 Series X grant increased direct ownership to 7,200 preferred shares. Series X has a $400 stated value; conversion terms and underlying common shares remain subject to counsel review.

	/s/ Brian Valania	08/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR